Newly Diagnosed?
GCS Resources
Connect with a Physician
Community Forums

What is Gynecological Carcinosarcoma?

Gynecological Carcinosarcoma (GCS) is a rare and aggressive cancer found primarily in the ovaries and uterus and can also originate in the fallopian tubes and vagina. GCS, is also known as MMMT or malignant mixed Müllerian tumor. Carcinosarcoma is unique in that it contains two types of cells; carcinomatous (epithelial tissue) and sarcomatous (connective tissue). GCS is rare. Fewer than 1,000 cases of GCS are diagnosed each year. Because carcinosarcoma is so rare, there has been limited research or clinical trials that focus on GCS. Unfortunately, this is where the cures will be found. Little or no research results in no cures or effective treatments for us. In order for us to have a fighting chance, we must aggressively support new and ongoing research so that Not One More Woman Will Die from this rotten cancer.

Are You A Candidate for Clinical Trials?

Identifying and supporting GCS specific clinical trials is a major component of our mission.

Learn More

Get Involved

Join this amazing community providing hope, answers, resources & support!
GCS Stories
Help Build Our Experts Knowledge Base

GCS News

The latest news and most engaged discussions from our website.
Keytruda & Lenvima

Hello. I was diagnosed with stage IVb metastatic in 01/2019. After surgery & hysterectomy, I went through 6 cycles of chemo. Cancer still there and growing. My new treatment will start next week, and it will consist of a combination of Keytruda & Lenvima ( Anybody have any experience with this treatment?

Books on Healing and Surviving Cancer

Post the surgical removal of one of the sarcoma masses the blocked my digestive system, I’m feeling much better. The mass has been sent in for analysis, and once again, there are no “treatments on the shelf” that we can apply for immunotherapy. However, my oncologist is both a researcher and immunotherapy specialist and he’s […]

New Clinical Trials for Patients with GYN Carcinosarcoma

We are pleased to announce that our consultant, Dr. Rebecca Arend of the University of Alabama at Birmingham (UAB), currently has two clinical trials that are dedicated to the treatment of carcinosarcoma patients! Trial using Cabo, Opdivo and Keytruda for GYN Carcinosarcoma ( Identifier: NCT 04149275) This trial is tailored specifically for recurrent carcinosarcoma patients. […]

View More